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iABSTRACT
Disturbed mineral and bone metabolism is frequently found in
very low-birth-weiljilt infants fed breast-milk during the
first three months of life. The study was designed to assess
the prevalence of this disturbed mineral homeostasis in a
very low-birth-weight populatiun at Baragwana,th Hospital and
to determine whether the addition of a preterm infant formula
to the feeds reduced the prevalence and increased the rate of
weight gain. Fifty three n80nate8 weighing less than 1200g
born at Baragwanath Hospital were monitored for weight gain,
growth and for biochemical and radiological evidence of
metabolic bone disease. The infants were randomized to
receive either breast-milk only feeds or a c~mbination of
breast-milk and a premature formula in order to assess the
effect of the different feeds on t.he.development of bone
disease. Weight gain and growth were similar in both groups.
Calcium and phosphorus intakes were higher in the mixed
feeding group. However, serum calcium and phosphorus values
were similar in the two groups throughout the study. The
breast-milk group had significantly higher alkaline
phosphatase levels. Radiological rickets was uncommun in
both groups, although periosteal reactions and osteopenia
occurred frequently and with similar prevalence in both
groups. Overt rickets is not a major pr.oblem in very~low-
birth-weight infants born at Baragwanath Hospital, although
raised serum alkaline phosphatase values occur frequently.
Feeding with breast-milk and a premature infant formula in
ii
equal pr.",'p,:>rtions(as opposed to breast-milk only) does not
appear to have any effect on weit.,1htgain and growth in very
low-birth-weight infants, but does partially prevent the
pathological rise in alkaline phosphatase levels.
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vPREFACE
Metabolic bone disease is a well recognised problem in low-
birth-weight infants, the reported incidence varying from 13
to 32%. It is more prevalent in those infants born weighing
less than 1200g Cindthe supplementation of calcium and
phosphate to the milk feeds of very low-birth-weight infants
has been shown to decrease the prevalence of metabolic bone
disease. In view of Baragwanath Hospital policy of
encouraging the use of breast feeding where possible as well
as the Lack of information on the prevalence of this problem
in these very small infants at Baragwanath Hospital, it was
decided to study t.~ prevalence of rickets in infants under
1200g on the basis of biochemical and radiological evidence
as well as assessing the effect of a premature infunt formula
on the prevalence.
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CHAPTER 1
INTRODUCTION
Metabolic bone disease is a collecl~iv6 term indicative of a
generalized disturbance of bone homeostasis, gener.ally
resulting from an abnormality in the factors influencing bone
formation and/or mineralization and bone resorption.
In the very low-birth-weight (VLBW) infant the disease rant;res
from mild biochemical abnormalities with no radiological
abnormalities, through mild under-mineralization to se'lere
rickets with fractures (1, 2).
The pathogenesis of the bone disease has been attributed to a
number of factors including deficiency of calcium, phosphorus
and/or vitamin D (1, 3, 4).
In this chapter, I shall briefly discuss normal bone
metabolism and mineralization as well as the factors that
affect these processes, prior to reviewing in detail previous
work on metabolic bone disease in VLBW infants.
1. BONE AND ~HE VITAMIN D ENDOCRINE SYSTEM
1.1. BONE
Bone is a composite of a hard, crystalline mineral and a
microfilbrillar matrix into which mineral is incorporated.
Prior to mineralization, bone matrix which is composed
/
/2
largely of collagen fibres, is deposited in lamellae.
Mineralization of this matr~x then occurs. This mineral is
mostly in the form of a complex salt that is regarded as a
hydroxyapatite with the basic formu.la ca~O(P04)6(OH)2.
N~arly 90% of calcium and phosphorus ions resides in these
hydroxyapatite crystals. Bone tissue, thus provides an
enormous reservoir of both calcium and phosphorus that can
function to stabilize the concentrations of these ions in
extracellular fluid. Bone mineralization is in turn directly
dependent on the concentration of calcium and phosphate at
the site of minerali2ation. It is also indirectly dependent
on the circulating con~entrations of calcium and phosphorus
regulating hormones and nutritional facto~s (Table 1). The
endocrine effects on bone mineralization "lill be discussed in
greater detail in section 1.2.
TABLE 1 ..Factors affecting bone mineralization
Required at bone site
Adequate concentration of calcium and phosphate
Normal pH
3
"~
Endocrine dffects on mineralization
1. Increases bone resorption
a. r 7 increasing osteoclast formation
_• .i?TH
- 1,25 dihydroxyvitamin D
- thyroxine
- growth hormone
2. Decreases bone resorption
a. By decreasing osteoclas·t formation
- calcitonin
- glucocorticoids
- oestrogens
b. By increasing osteoblast formation
- calcitonin
- oestrogens
- growth hormone
Nutritional effects on mineralization
1. Required for adequate mineralization
a. vitamin D
b. calcium and phosphorus
c. magnesiuTl
d. zinc
e. copper
2. Inhibitors of mineralization
a. magnesium
b. aluminium
c. fluor';'de
Bone is also a growing living tissue which undergoes growth
and continual r.emodelling in order for ~ to provide
mechanical support and protection. In a growing infant and
child, the epiphyses are separated from the diaphyses by a
cartilaginous grol'lthplate and linear growth 02 tubular bones
occurs at this epiphyseal growth plate (Figure 1).
4Metaphysis
FIGURE 1. Schematic represEllltution of bone illustrating
different regions.
The initial step in bone mineralization is oalcification of
the cartilage rc the metaphyseal side of the epiphyseal plate
forming the prov.i.sional zone of calcification. The formation
of new bone at the metaphysis is then preceded by the
resorption of the calcitie~ oartilage and reprecipitation of
mineral in the new matrix laid down~by osteoblasts that line
the invading capill~ries.
Linear bone growth ceases after epiphyseal closure. continual
remodelling of bone occurs primarily at the trabecular bone
surface. Resorption of bone mineral by osteoclasts is
followed by new matrix f.ormation and minel"alization of this
matrix.
1.2. CALCIUM AND PHOSPHORUS HOMEOSTASIS
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1.2.1. Hormones of calcium and phosphorus homeostasis
Calcium and phosph0rus are essential to a great number of
cellular functions, thus the extracellular levels of these
ions (in particular calcium) are finely controlled. The
maintenance of calcium and phosphorus homeostasis involves
the delicate inter-relationships of absorption by the
intestine, accretion and resorption by bone tissue and by
filtration and reabsorption by the kidney. The three
principal hormones involved in calcium and phosphorus
homeostasis are vitamin 0, parathormone (PTH) and calcitonin.
(Table 2) .
TABLE 2. Actions of vitamin 0, parathormone and calcitonin in
calcium and phosphorus homeostasis.
EFFECT CALCITONIN PTH VITAMIN D
INTlESTINA L
ceaum absorptIon
Phosphate absorption
RENAL
Phosphate excretion
CalcIum excretIon
Hydrogen excretIon
PotassIum excretIon
SodIum excretIon
Adenyl cyclase actIVIty
SKS'LlETAL
Calcium mobilization
MineralizatIon of bona matrix
OTHFiR
Plasma levels of calolum
Plasma levels of phosphate
Body weight
~?
?
t
t
t
t
-+
Slight t
t
t
+
f
t
t
~
+
?
?
?
?
t t
t
t
+
?
61.2.1.1. Vitamin D physiology
The physiology of vitamin D (vit D) has been extensively
reviewed C 5 I 6). The l.letabolicconversions undergone by,
vitamin D in order to fulfil its hormonal functions are
depicted in Figure 2.
24,25 (OH)2 D
PARATHYROID
GLANOS
1,24,26, (OH)3 0
Figure 2. Schematic overview of vitamin D - its sources,
activation and homeostatic control.
7vitamin D requirements are met from a combination of two
sources - sunlight and dietary intake. The first pro"eeds in
the skin where, upon exposure to ultraviolet irradiativn
(290-320nm), 7-dehydrocholesterol is first photochemically
converted to precholecalciferol (previtamin D) in the stratum
Malpighii. This is then converted more slowly by molecular
re-arrangement into vitamin D3 (cholecalciferol) (Figure 3)
and released into the circulation over 2 - 3 days. This
pathway is the natural source of antirachitic activity when
exposure to sunlight is adequate.
luml.torol
+
tachysterol
W l'ght _IV.
HO <, (290 - J20nr;.Y/
7-d.hydrocholo.t.rol ~ Y
provitamin 03
CII,
~h.at
Figure 3. The photosynthetic conversion of 7-
dehydrocholesterol by sunlight to vitamin D3'
8The second important source of vitamin D available to man is
ergocalciferol (vitamin D2) which aris~s from Ultraviolet
irradiatio~ of ergosterol present in plants and is generally
known as dietary vitamin D. The main dietary sources of
vitamin D2 are fortified dairy products and fish liVer oil.
On a weight basis, 25ng of vitamin D2 has been designated as
1 international unit (IU) of antirachitic activity. The
recommended daily allowance of vitamin D for children is
4ooru, although dietary requirements depend on the amount of
vitamin 0 formed in the skin under ultraviolet irradiation.
Vitamin D3 (endogenous) and vitamin D2 (exogenous) are
transported in the plasma bound to a specific alpha-2-
globulin known as vitamin 0 binding protein (DBP). Vitamin D
absorbed from the gastro-intestinal tract is transported in
chylomicrons in the lymphatics.
Depending on the vitamin D status of the individual, vitamin
D is either deposited in the body stores or'taken up by the
liver and converted to 25-hydroxyvitamin D (25-0HD). 25-0HD
is the major circulating form of vitamin D and is t.ransported
in the blood bound to DBP to the kidney. There it is
converted to the active metabolite, l,25-dihydroxyvitamin D
(l,25-(OH)2D). A further metabolite, 24,25-dihydroxyvitamin
Dr is also formed in the kidney along with several other
9relatively inactive metabolites.
The formation of 25-0HD does not appear to be strictly
controlled, but the formation of 1,25-(OH)2D is regulated in
a feedback fashion by plasma calcium and phosphorus
concentrations (Figure 4).
10
Ca - calcium
C++ - ionized calcium
p .- phosphate
OHase- hydroxylase
~ positive feedback
........ negative feedback
PARATHYROIDS
+ Serum P
t Serum P
10: -OHase •
25 (OH) D lIP 1,25 (OHh D ~
~~ ...~ ....
•
/
24,25 (OHh D INTESTINE
KIDNEY
~ a .~ a m a _ ••••• a _ Q ••• ~ ~ •••• m m _ • ~ •••• _.
Figure 4: Feedback control of the formation of the active
vitamin D metabolite 1,25 dihydroxyvitamin D.
1.2.1.2. Parathyroid hormone
parathyroid hormone (PTH) is secreted by the parathyroid
glands. Its action is to increase the plasma concentration of
\
ionized calcium by directly m~bilizing calcium from bone, and
increasing renal tubular reabsorption of calcium. It also
increases the formation of 1,25 dihydroxyvitamin 0, the
physiologically active metabolite of vitamin D which controls
the intestinal transport of calcium and phosphate. PTH also
depresses the plasma phosphate by decreasing renal tubular
phosphate reabsorption (phosphaturic action).
The major controlling factor in determining the rate of PTH
synthesis and release is the concentration of calcium ions in
the fluid perfusing the parathyroidWgland. When the plasma
ionized calcium level is high, secretion of PTH is inhibited
and calcium is deposited in the bones. When serum ionized
calcium is low, the reverse occurs. Elevated plasma
phosphate levels stimulate PTH secretion, but only through
their secondary effect of lowering the plasma ionized calcium
concentrations.
1.2.1.3. calcitonin
Calci.tonin is a cctlcium lowering hormone that is secreted
primarily by the parafollicular cells of the thyroid gland.
It acts by inhibiting bone resorption. Its role in normal
12
bone physiology is probably minimal.
The effects of these calciotropic hormones are summarized in
Figure 5.
~
EXTRACELLULAR
~Ca P
PTH t ~
VITD t t
CT .(. ~
+
Figure 5. calcitropic hormones and their actions on target
organs and effects on serum calcium and phosphorus.
1.2.2. Calcium homeostasis
The adult human body contains about 1100g of calcium, mostly
found in the skeletal system as hydroxyapatite (as discussed
in section 1.1). The plasma calcium, normally about
2.5mmol/l, is partly protein bound and partly ionized (Table
3) •
.'
TABLE 3. Distribution of calcium (mmol/l) in normal human
plasma.
Diffusable
Ionized calcium
complexed to HC03-, citrate, etc.
Nondiffusable (protein-bound)
Bo~nd to albumin
Bound to globulin
1.34
1.18
0.16
1.16
0.92
0.24
2.50Total plasma calcium
The physiologically important fraction is the ionized
fraction, which plays a role in essential cellular processes
such as coagulation, normal cardiac function and skeletal
muscle and nerve function. It is, therefore, essential that
ionized calcium is finely controlled.
Calcium absorption from the gu·t (primarily in the duodenum
and jejunum) is controlled by the body's need for caloium and
thus all the caloium ingested is not neoessarily abs">;,bed. In
adults intestinal oaloium absorption is both aotive and
passive. The former is saturable and greater for individuals
previously adapted to low oalcium intake. Passive transport
is direotly proportional to intraluminal oalcium
concentration.
Intestinal caloium absorption is oontrolled largely by the
concentration of 1,25-dihydroxyvitamin D (Figure 6). Low
serum oaloium also stimulates PTH secretion whioh stimulates
1,25-dihydroxyvitamin D formation in the kidney and thus
increases calcium absorption. Increased calcium absorption
during active growth, pregnancy and lactation in order to
maet increased calcium requirements is mediated not only
t~iroughPTH, but also by the action of growth hormone,
oestrogens and pr.olactin through their control of 1,25-
dihydroxyvitamin D production.
calcium absorption is decreased by cortisol and other
steriods with glucocorticoid properties, malabsorptive states
(particularly fat malabsorption) and the presence of large
amounts of phosphate or phytate in the gut.
In the event that dietary intake or availability of calcium
is decreased, the regulatory role of bone and kidney come
into play to maintain a constant serum calcium level. Thus,
serum calcium may become 2levated through stimulation of bone
resorption or through PTH stimulat'~on of tubular reabsorption
of calcium in the kidney. Concomitantly, PTH stimulates
phosphate excretion, so that as serum calcium concentration
increases, there is usually a fall in plasma phosphate level.
On a daily basis, the renal glomeruli of ~n adult filter some
lOOOOmg calcium, but renal tubular reabsorption is so
efficient that under normal circumstances only 100-150rog
appear in the urine. In the event of hypercalcaemia, the
urinary excretion of calcium rises in a compensatory fashion.
.'
.... i,./·
The renal tubular reabsorption of calc ..um is stimulated by
PTH, Increased urinary e:xcret:l.onof calcium is c:timulated by
phosphate deprivation, acidosis, adrenal steriods <.nd saline
diuresis.
1.2.3. Phosphate homeostasis.
Under normal circumstances, inorganic phosphate is present in
plasma of an adult at a 18vel of approximately 1.2mmol/l (2.5
- 4.3mg/dl) in adults. Approximately 10% of this is protein
bound. The remainder exists as free phosphate, either HP042-
or H2PO.'J,-'Phosphate is also required as organic phosphate in
Which it fUnctions in enzymatic and structural proteins.
Phosphate in the body is partitioned among 3 major pools: the
lcidney ultrafiltrate, the readily exchangeable bone fraction
and the intracellular compartments of %oft tissues. The
dynamics of phosphate metabolism are not particularly
different from those of caLcLum , trnder normal circumstances,
approximately 70% of dietary phosphate is absorbed. This is
not as closely controlled as calcium absorption and plays a
relatively minor role in phosphate homeustasis. Absorption of
phosphate is interrelated in a complex fashion with the
presence of calcium and can be stimulated by a 10", calcium
diet as well as by vitamin D or its metabolites (Figure 5).
The intestinal absorption of phosphate is inhibited by high
dietary calcium levels, aluminium hydroxide ingestion and
other divalent cations with which it forms ~~solu~le
•'I
• <
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phosphates.
Phosphate is excreted mainly by the kidney, this ~eing the
major controlling mechanism of serum phosphate levels. The
control of renal excretion of phosphate can be explained by a
reabsorptive tubular maximum function (TmP). When the
quantity of phosphate filtered decreases below the maximum
reabsorptive capacity, tUbular reabsorption of phosphate
becomes more complete. The handling of phosphate by the
kidney Ls determined by the glomeruLar filtration rate (GFR) I
tubular reabsorption and possibly a minor role by tubular
secretion. The equilibrium co~centration (TmP/~FR) is used as
a measure of tubular reabsorption of phosphate in relation to
renal function. This equilibrium concentration is influenced
by age and maturity. This explains the variation i1"1serum
phosphate with age (Table 4). The high TmP/GFR of the infant
and child with normal vitamin D staof:usduring the growth
period maintains high concentrations of oerum phosphate
during this period. This is obviously important in the rapid
miner.ali2ation of cartilage and bone.
TABL~ Changes in serum phosphate with age.
AGE
2.5
2.0
1.5
1.2 J
SERUM Pi (mmol/l)
Premature infants
Full ~erm infants - first week
1 to 10 years
Adult
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As already indicated, the major endocrine function of PTH is
to regulate the tubular reabsorption of phosphate. Thus high
circulating levels of PTH stimulate the urinary excretion of
phosphate by block±ng tubular reabsorption of inorganic ion
present in glomerular filtrate (Figure 5). other hormones
such as calci 1"onin, thyroid hormones and growth hormone ,
probably through the action of insulin growth factor-l, also
influence the renal handling of phosphate.
1.2.4. CONCLUSIONS
A complex inter~relationships exist between bone, calQium,
phosphate and the various hormones controlling these
processes. Normal vitamin D status and adequate calcium and
phosphate supplies are requil~ed for"adequate bone
mineralization. Bone, in turn, provides a reservoir for both
calcium and phosphate with movement of these ions into and
out of bone.
, ,
,.~ ., I
,
1.3. ,CALCIUM! PHOSPHORUS AND VITAMIN D METABOLISM IN THE
PREMATURE NEONATE
The needs of the premature neonate differ from those of the
term neonate, infant and adult as the premature neonate has a
farter growth rate, has many physiologicql fU~lctions that are
immature and has also not had t~;ebenefit of completing
gestation in an optimum intra,-uterine environment.
Therefore, it is important to consider the calcium,
phosphorus and vitamin D requirements and metabolism of the
premature. infant specifically. I will discuss these
requirements in the newborn premature infant and then discuss
the diagnosis, pathogenesis and prevention of metabolic bone
disease in this group of neonates. •
1.3.1. Calcium and phosphorus
In the foetus, 80~ii of the calcium and phosphorus accretion
required for bone mineraliza'tion occurs during the third
trimester (7). The foetus at 25-36 weeks grows at a rate of
approximately 25g/day and accumulates 100~120mg/kg/day
calcium and GO-75mg/J<.g/dayphosphorus (Table 5) (8). These
accretion rates are the highest that an individual will
attain throughout life. Although calcium and phosphorus
metabolism are linked, the handling of these minerals in the
premature neonate will be discussed separately.
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TABLE 5. Daily increments of body weight, calcium and
phosphorous in the foetus.
39
83
123
212
179
Gestational Weight calcium
age (weeks) (g) (mg)
24-25 11.4 61
28-29 22.6 129
32-33 27.1 193
36-37 35.7 341
39-40 17.1 302
Phosphorus
(mg)
1.3.2. Calcium in the prematu~e neonate
1.3 .2.1. Requirements. caLc.i.uu. requirements in utero are met
by active calcium transport across the placenta. Maternal
adjustments to the calcium drain have been extensively
investigated and reviewed (9, 10), but are not relevant to
the current discussion. Following premature birth and the
loss of maternal supplies, calcium requirements must be m~t
by external sources. In order to establish the nutritional
requirements of the premature infant, Zieglel' et al (8) have
used the factoricll method. This method supposes that calcium
retention must be the same as that of a foetus of the same
gestational age and it calculates the supply of calcium
taking into account the assumed losses through skin, urine
and stools. Based on this, they have calcUlated that
premature neonates of 1000g and 1500g should receive 210mg
and 185mg calcium per kilogram body weight per day,
respectively. These in utero accretion rates are difficult
{ .
to achieve using conventional infant feeding methods of human
milk or milk formulae. The premature infant on ma:x:imUlnoral
feeds of 200ml/kg/day of human milk will ingest only 50-
60mg/kg/day calcium (compared with approximately 200mg/kg/day
required to match in utero accretion rates). Milk formulae,
specifically designed for use in premature neonates have
increased ca1cium (and phosphorus) content in order to
approximate in utero accretion rates. Table 6 summarizes the
calcium and phosphorus contents of breast-min: and the
commonly used milk formulae. ThUS, the amount of calcium
ingested by the neonate is less than that required to equal
in utero accretion rates.
TABLE 6. comparison of intrauterine calcium (ca) and
phosphorus (P) accretion rates, daily requirements
with that supplied in hUman milk and various milk
formulae at 200ml/kg/day.
ce (mg/kg/day) P (mg/kg/day)
In utero acr.~·etionrates 100-120 60-75
Recommended daily intake 200 110-125Mature human :milk 50-60 28-40
Humanized milk formula 80 40
ego S26 (Nestle)
Premature infant formula 120 60
ego Alprem
Soy-based fOrmula 140 90
1.3.2.2. Absorption. The suboptimal amount of calcium
ingested is fUrther aggravated by the fact that calciUm
absorption in premature infants is rarely complete, ranging
from 29-80% and is influenced by a multitude of factors. As
mentioned previously, calciUm absorption from the gut is both
active (1,25-dihydroxyvitamin D dependent) and passive. It
appears that passive absorption does not play an important
role in premature infants although it might do so in newborn
rats. This evidence was suggested by Senterre et al (11) who
demonstrated that in the absence of administered vitamin D,
the amount of calcium absorbed by the premature infant is
very small, even if calcium intake is increased. In contrast,
the administration of vitamin D results in a clear
augmentation of calcium absorption (11). The vitamin D supply
of the premature infant must be adequate to maximize calcium
absorption. The metabolism and requirements of vitamin D in
the premature will be discussed in section 1.3.4.
Numerous other factors that affect calcium absorption must
also be considered. Calcium absorption is increased by a high
"'calcium intake (-12), lactose containing formulae (mechanism
unknown) (13) and increased gestational age. The amount and
type of fat present in the intestinal lumen also affects
calcium absorption. Increased steatorrhoea in the premature
infant secondary to reduced bile salt concentration is
accompanied by an increased faecal calcium loss (14). The
reverse also holds true and an increased calcium supply
aggravates fat malabsorption (15). This can be explained by
the reduction in bile acid concentration in the neonate which
decreases long chain saturated fatty acid absorption and
these together viith calcium form Lnsoluble soaps. Chapell et
al (15) showed that the replacement of long chain sat\.lr.:tted
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fats with medium chain or polyunsaturated fatty .cids
improved calcium absorption.
calcium absorption is also affected by the amount of
phosphate ingested relative to amount of calcium present.
A calcium:phosphate ratio of 2:1 (as is found in hUman milk)
appears to be optimum for calcium absorption, although milks
with lower caLcdums phospho.rus ratio have similar percentages
of calcium absorption.
1.3.3. Phosphorus in the premature neonate
1.3.3.1. Requirements. The amount of phosphorus in the foetus
from 2a-40 weeks rises from 3,4g to 16,8g corresponding to a
daily accretion rate of 65-70mg/kg (Table 5) (8). Assuming
that phosphorus retention in the neonate must be the same as
that of the foetus in order to achieve in utero accretion
rates, the estimated oral requirement of phosphorus in low-
birth-weight babies is 110-125m~/kg/day (8, 16). Phosphorus
content of human milk varies from 110-170mg/l (Table 6), thus
at maximum feeds of 2OOml/kg/day I 28-40mg/kg/day phosphate
are ingested, which are insufficient to meet the in utero
accretion rates to ensure both cell growth and incorporation
of calcium and phosphate into bone.
1.3.3.2. Absorption. Phosphorus absorption in the premature
and term neonate fed human milk or modified formulas is
higher than that of calcium, ranging from 80-94% (11). It
..
seems to be independent of both vitamin D and calcium (11) as
opposed to calcium absorption which is dependent on both
vitamin D and phosphate supply.
1.3.4. vitamin D status and metabolism in premature infant~
1.3.4.1. In utero. The foetus is dependent on maternal
vitamin D status as placental transfer of maternal vitamin D
and its metabolites occurs. There is a direct correlation
between maternal and foetal 25-0HD at birth and it appears
that this is the major vitamin D metabolite to be transferred
across the placenta (17, 18). The source of foetal 1,25-
(OH)2D is uncertain. placental transfer has been
demonstrated, but the majority of studies fail to show a
correlation between maternal and foetal levels (18). The
placenta and foetal kidney are capable of metabolizing
transferred maternal 25-0HD and it appears that the foeto-
~placental unit supplies its own primary source of l,25-(OH)2D
(19). The role of these metabolites in placental calcium
transport and foetal mineral homeostasis is unclear. After
birth, there is a rapid rise in 1,25-(OH)2D under the
influence of PTH (20). This increase is directly proportional
to the concentration of 25-0HD and therefore reflects
maternal vitamin D status. LoW maternal and hence, low
neonatal serum 25-0HD levels have been recorded in
hypocalcaemic neonates (21), but the effect of maternal
vitamin D status on foetal bone mineralization is less clear
(22) as congenital rickets has been described.
{ .
1.3.4.2. Post-delivery. After delivery, the neonate has
obviously lost the materna-placental unit as a source of
vitamin D and is now dependent on dietary v i.t.au.m D as
ultraviolet light exposure is minimal. The vitamin D
requirements of the preterm newborn are controversial, but
appear to be greater than those of the term neonate. Hoff et
al (23) and cifuentes et al (24) have reported rickets in
premature babies receiving up to 400IUjday vitamin D which
have healed on increased vitamin D supplementation. In a
study by Hillman et al (25) a significant number of 10'1'1-
birth-weight infants showed biochemical and :radiological
evidence of rickets despite supplementation with 400IUjday
vitamin D. Hilllnan et al (26) sucaequent.Ly demonstrated that
vitamin D requirements are better covered by a daily dose of
800IUjday. These infants had higher 25-hydroxyvitamin D, less
whypophosphataemia and less radiographic evidence of
osteopenia than those infants given 400IUjday.
It is uncertain why the premature infant has Inez-eased
vitamin D requirements. Vitamin D status of the neonate at
birth, reflecting maternal vitamin D status may partially
explain the discrepant vitamin D requirements as found in the
various studies (27). Immaturity in the pathway of normal
vitamin D metabolism, i.e. either at intestinal, hepatic or
renal level, may also account for increased vitamin D
requirements and must be cOl1sldered.
if "
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1.3.4.3. Absorption. Intestinal absorption of vitamin D seems
adequate in the preterm infant (28), although this may not
necessarily be so in the VLBW infant. Factors increasing
vitamin D absorption are the dose of the vitamin
administered, the presence of an acidic intraluminal
environment and micelle formation which is essential for fat
absorption. The premature infant has a lower intraluminal
secretion of bile a_ids (29) (which are required for micelle
formation), and a reduced efficiency of fat absorption, which
may result in poo're.rvitamin D absorp·tion.
1.3.4.4. Hepatic metabolism. Hepatic hydroxylation of vitamin
D has been shown to be adequate in healthy preterm infants in
a number of studies (30, 31). Glorieux et al (30), Robinson
et al (31) and Salle et al (28) were able to demonstrate a
rise in serum 25-hydroxyvitamin D levels in premature infants
born after 28 weeks gestational age after administration of
vitamin D (dosages ranging from 500-2100IU/day). Work by
Hillman and Haddad (32), however, failed to show an increase
in 25-0HD following vitamin D administration until 36-38
weeks gestational age, suggestive of immaturity of hepatic
hydroxylation until that age. Hillman et al (26) iater
confirmed that serum 25-0HD levels did rise in premature
infants given 400-800IU/day, but that these serum levels were
lower than expected. Thus, decreased hepatic hydroxylation 01
vitamin D in premature infants does occur, but is of doubtful
significance.
(" , .
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1.3.4.5. Renal metabolism~ Renal hydroxylation of 25-0HD to
1-25 (OH)2D in preterms also appears to be adequo.te. Plasma
1,25-(OH)2D has been demonstrated to increase sjgnificantly
in premature infants (28-36 weeks gestational age) (33).
Glorieux at al (30) confirmed a three-fold increase in 1,25-
dihydroxyvitamin D levels in premature infants (32-37 weeks
I ,stational age) after administration of high dose vitamin D.
Serum 1,25-dihydroxyvitamin D levels have been found to be
normal or even increased in preterm infants with rickets (34,
35), and Markestad et al (36) speculate that this represents
a normal compensatory effort to ensure maximal absorption
from a mineral poor diet.
1.3.4.6. Conclusion. Numsrous studies on vitamin D metabolism.in premature infants indicate minimal disturbance in
function. studies on vitamin D supplementation in this group
of infants indicate that 800IU/day vitamin D should be the
current recommended dose, as rickets has been described in
VLBW infants receiving less than this (400rU/day vitamin D)
and no advantages have been demonstrated in giving more than
this amount.
1.4. RICKETS
The VLBW infant not only has perturbations of mineral
homeostasis, but frequently manifests features of metabolic
bone disease including rickets.
-,. '
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1.4.1. Definitions
Ricketc; is a disorder of growing bones manifesting as a
delay in mineralization of the cartilaginous matrix at the
epiphyseal growth plate and of preformed osteoid at the
metaphys~al regions of long bones.
- osteomalacia refers to the failure of mineralization
occurring in bone remodelled at the trabecular bone surface
and within cortical bone.
osteopenia implies a generalized decrease in mineral
content of bone.
The changes in bone tissue that occur concomitantly with
vitamin D deficiency, or calcium and phosphate deficiency are
failure of normal mineralisation of bone matrix, ultimately
leading to an increased aocumuLat.Lon o:E unmineralized
osteoid. These changes may be seen rad:Lologically at; the
epiphyseal ends of long bones (particularly the wrist) as
widening of the epiphyseal growth plate with cupping and
fraying of the 'r' ..~taphyses I and in the diaphysis as thinning
of the cortices and periosteal new bone formation.
1.4.2. Aetio..1.Q.gy
The aetiology of rickets may be broadly divided into two
groups depending on whether the basic defect is a failure to
maintain ionized serum calcium or phoaphor-us cancentrations
within the normal range for age.
The following table lists the causes of ~ickets which is
applicable to all age groups. (Table 7).
TABLE 7~ Aetiological classification of rickets.--------------~
Calcium deficient
Inadequate formation of 1,2S-(OH)2D
Vitamin D deficiency
-dietary lack
-lack of sunlight exposure
-malabsorption syndromes
Failure of hepatic hydroxylation
-severe liver disease
Increased vitamin D metabolism
-anticonvulsant therapy
Failure wf renal ~ydroxylation
-renal failure
-vitamin D dependency type J.
Inadeqt.a.te oalcium intalce
Dietary calcium deficiency
High fluoride intake
Phosphate deficient
Inadequate vhosphate absorption
Dietary lack
Binding of dietary phosphate within the bowel
Increased renal losses
Renal phosphate leal
-hypophosphataemic vitarrdn D-resistent rickets
-hypercalciuric vitamin D-resistent rickets
-tumour associated
-associated with neurofibromatosis
-associated with polyostotic f:i"rous dysplasia
Complex renal tubul:lr ubnormalities
-proximal tubular defect
-primary: Fancni's syndrome, Lowes' syndrome
-secondary: galactosemia, Wilson's disease
-distal tubular defect
-distal renal tubular acidosis
!:liE1cC:l;Llaneous
Hypophosphatasia
28
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1.5. METABOLIC BONE DISEASE IN PREMATURE INFANTS
The improved sl'.rvivalof very low-birth-weight premature
infants during the 1970's and 1980's has been accompanied by
an increased incidence of metabolic bone disease (MBD) in
this population. Also known as rickets of prematurity, this
syndrome encompasses a spectrum of abnormalities of bone
metabolism. This spectrum ranges from the severest form in
which marked rickets and fractures occur, to the milder forms
in which radiological r.arefaction (osteopenia) and elevated
alkaline phosphatase levels are found.
1.5.1. Incidence
The exact incidence of metabolic bone disease is unknown
because of the difficulty of diagnosis and the large number
of subclinical cases. McIntosh et al (37) have shown that it
becomes progressively more common and more severe with
decreasing gestational age and birth weight and is
particularly common in neonates af less than 1000g birth
weight. Several studies have estimated a 30% incidence of MBD
in preterm infants weighing less than 1500g at birth (38,
39). In neonates with a birth-weight of less than 1000g,
reduced bone minE"lralizationwas demonstrated in about 759" of
cases at 3 weeks of age (37, 39) and frank radiological
rickets in 57% of these neonates (37). Rickets, fractures and
bone demineralization in premature neonates usually present
f '
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between one and five months of postnatal age (40) I with most
cases presenting between two to four months postnatally (39).
Several factors appear to be important in predisposing the
premature neonate to the development of MBD (41):
1. It becomes progressively more common with decreasing
I
gestational age (25,37).
2. It is most frequent in the breast-fed premature infants
(42), but has been reported in infants on standard ~nfant
milk formulas (43) or soy milk preparations (40).
3. It occurs more frequently in infants who have had
prolonged period of parenteral nutrition (44) or prolonged
illness (4, 45).
1.5.2. Diagnosis
The classical clinical signs of vitamin D deficiency rickets
are frequently not apparent in the premature infant as MBD is
often subclinical (39, 46). It may be an incidental finding
on routine chest radiography (40, 47) Or suspected in an
infant with rib fractures, often subsequent to physiotherapy
(47). The diagnosis may then be confirmed on biochemical
data, radiography or bone histOlogy.
1.5.2.1. Biochemical testing. Serum calcium and phosphate
levels vary markedly and although these levels may be useful
indicators of the presence of rickets, they are not
diagnostic (4). Serum calcium concentration is of~en normal,
but may vary from low to elevated, the latter usually
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occurring in the presence of low serum phosphorus levels
(38). Serum phosphorus concentrations are frequently low, but
may also be within normal limits. SerUm alkaline phosphatase
(ALP) activity is also not a reliable indicator of rickets of
prematurity. In most instances the ALP level w.":'lbe raised,
(44), but its significance as an indicator of bone disease in
the neonate is controversial. due to the presence of non-bone
isoenzymes. ALP is also produced in the liver (48) and
concentrations are raised in the presence of liver disease,
especially in obstructive ja1,mdice in association with a
raised gammaglutamyl transferase. In such situations ALP
cannot be used as an indicator of bone disease unless iso-
enzymes are measured. In bone itself, ALP is an indicator of
osteoblastic activity (48). The high serum ALp levels in
preterm infants with or without rickets may thus reflect a
normal response to a physiological increase in osteoblastic
activity and bone mineralization associated with rapid
growth. It has been suggested that ALP values of fivQ times
normal adult values may be normal in preterm infants. In a
study by Glass et al (44), all patients with metaphyseal
changes had maximum ALP activity greater than 750IU/l.
periosteal reactions were seen only if values exceeded
10001U/1. Kovar et al, (49) suggest that AI~P values six t,imes
normal adult values indicate the need for radiological
assessment and a value 7.5 times adult values is indicative
of active rickets. The diagnosis of MBD based on abnormal ALP
levels, must therefore be confirmed radiologically.
f "
1.5.2.2. Radiological assessment. The radiological changes
found in MBD are osteopenia, periosteal reactions and frank
rickets. Various grading systems have been proposed in an
attempt to sta~dardize the radiological findings. Koo et al
\
(39) have suggested the following classification which proves
satisfactory in practice :
Grade 0 - Normal bones.
Grade 1 - Rarefaction only, i.e. loss of dense white line
at metaphyses, increased sUbmetaphyseal lucency and
cortical thinning.
Grade 2 - Bone end changes (fraying and cupping of
metaphyses), subperiosteal new bone formation.
Grade 3 - The above changes with fractures.
1.5.2.3. Photon absorptiometry. This is probably the best
technique currently available for measuring bone mineral
content, but is largely a research tool as equipment is
expensive and not generaJ.ly available. A number of studies
have shown this method to be a reliable measurement of BMC in
preterm infants as well as a means of monitoring changes of
BMC with increasing age and different feeding regimes (50,
51). However, as single photon absorptiometry only measureS
the mineral content of bone, it does not distinguish between
osteoporosis and rickets.
(" ,
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1.5.3. Differential diagnosis
After a careful clinical examination, biochemical and
radiological investigations, there are few other conditions
that resemble rickets of prematurity. Trace mineral
deficiencies may occur in neonates with complicated postnatal
courses in particular with prolonged .hyperalimentation. of
these, copper defi<::liencymay present with similar
radiological change a to those found in rickpts of
prematurity. The changes of copper deficiency inclu1e
osteopenia, subperiosteal neW bone formation and blurring and
cupping of the long bone metaphyses (52, 53). Biochemical
investigations will differentiate between these two
conditions as in copper defici~ncy, serum calcium and
...phosphate concentrations are normal, but serum copper and
caerulcplasmin concentrations are decreased.
1.5.4. pathogenesis
Several pathogenetic mechanisms have been suggested to
eXplain the prevalence of bone disease in premature infants
and can be grouped as follows :
a. vitamin D deficiency or abnormalities of vitamin 0
metabolism.
b. Dietary calciuID and/or phosphorus deficiency.
Some of the factors that may be involved in the
pathogenesis of MBD are listed in Table 8 and discussed
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below. These factors are, in turn, influenced by vitamin D
supplementation, type of milk feed, severity of postnatal
problems, prolonged Use of parenteral hyperalimentation
and furosamide therapy as well as other as yet
unidentified factors.
TABLE 8. Aetiological factors in metabolic bone disease of
prematurity.
Calcium and phospll.orusdeficiency
- human milk, standard formula and soy feeds
- prolonged hyperalimentation
- fat malabsorption
- diuretics
- systemic disease and acidosis
Vitamin D related disorders
- dietary intake deficiency
- hepatic hydroxy tion of vitamin D
- renal hydroxylation of vitamin D
- end organ responsivenee;s
1.5.4.1. Role of vitamin D
A detailed description of vitamin D metabolism in the
premature baby has been o.iscussed (section 1.3 .4). No maj or
abnormalities in the absorpt Lon , hepatic or renal
hydroxylation of this vitamin in premature infants have been
delineated. vitamin D intakes of 800-1000IU/day may be
required to ensure adequate vitamin D absorption, hepatic
hydroxylation and optimum calcium absorption. Despite
adequate sUpplementation, biochemical evidence of rickets has
been documerrced in VLBW infants.
Thus there is little evidence that vitamin D is the primary
problem in the aetiology of metabolic bone disease in this
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group of infants, although a deficiency of vitamin D, if
adequate intake is not maintained, might increa:Je the
prevalence.
1.5.4.2. Role of calcium and phosphorus
Evidence of rickets in vitamin D replete pt'~mature infants as
well as minimal dysfunction in vitamin D metabolism is
suggestive of substrate (calcium and/or phosphorus)
deficiency (56). As has been previously discussed, many
premature infants of 25-36 weeks gestation can grow at a rate
similar to the in utero growth rate and have similar calcium
(lOO/120mg/kg/day) and phosphorus (60-75mg/kg/day)
requirements as the foetus in order to maintain adequate bone
mineralization. Human milk, at an intake of 150-200ml/kg
provides only 51-68mg/kg/day calcium and 21-28mg/kg/day
phosphorus (Table 6). Numerous studies have documented the
development of clinical and biochemical rickets in preterm
and very low-hirth-weight infants fed breast milk (54, 55,
57, 58), suggesting that human milk alone is inadequate to
meet the mineral needs of the growing preterm infant.
VLBW infants, especially those weighing less than 1000g (25),
have been sh~wn to develop metabolic bone disease when f~d
standard milk formulae. The calcium and phosphorus content of
these formulae are also insufficient to meet the bone
mineralization requirements of the VLBW infant (Table 6).
Several reports have documented a decrease in MBD in VLBW
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infants fed with calcium and phosphorus supplemented feeds
(43, .59,60) suggesting that both calcium and phosphorus
deficiency may playa role in the pathogenesis of MFD. ReClent
studies suggest that phosphorus depletion may play a more
significant role in this disease entity (57, 58, 61-63). Rowe
et al (62) showed that in preterm infants fed human milk
compared with those fed standard formula the serum phosphate
is significantly lower, the renal excretion of phosphate is
virtually zero (compared with 40% in the controls) and the
renal excretion of calcium is higher despite having received
one-half to two-thirds the amount of calcium. Supplementation
of the human milk fed infants with oral phosphate
(O.8mmol/kg/24hr) reversed these findings resulting in
r(~ducedurinary calcium loss, increased renal phosphate
excretion, and elevated serum phosphate without decreasing
serum calcium concentrations. PTH values remained normal
(64). These studies support the hypothesis of phosphate
deficiency syndrome in VLBW infants which is characterised by
the biochemical findings of hypophosphataemia,
hypophosphaturia and hypercalciuria (63) (Table 9).
TABLE 9. Biochemical findings in phosphorus defi~iency.
Hypophosphataemia
,'ypophosphaturia / High TmP/GFR
Hypercalciuria
Increased serum alkaline phosphatase
Normal (or increased) serum calcium
Normal serum PTH
> '" '
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'I.'hepathophysiologic consequences of phosphate deficiency on
hone mineralization are (lIeto both direct and indirect
effects of hypophosphataemia (63). Low extracellular
phoapt "Jtelevels may directly enhance bone resorption as well
as decrease matrix formation and bone mineralization (63).
The indirect effects of hypophosphataemia are depicted in
Figure 6. Decreased phosphorus ingestion leads to a decrease
in serum phosphorus concentration and virtually complete
renal tubular phosphate reabsorption. The low extracellular
phosphate concentration increases renal l-alpha-hydroxyl~se
activity resulting in elevated serum 1,25-(OH)2D levels. This
stimulates bone resorption (releasing calcium anu phosphate)
and increases intestinal calcium absorption. In the VLBW
infant this increased calciu~ may not be utilized in bone
mineralizatIon as phosphate is deficient and the "excess" is
excreted in the urine. Serum pJ '-~phateremains low despite
its release from bone as it .. t. essential
intracellular functions (65). :neva1:eo 1,25-(OH)2D inhibit in
vitro bone collagen synthesis which may contribute to MBD.
Serum PTH levels remain within the normal range as does serum
calcium (which is the mai. imulus for its release). The
effects of phosphorUs and 1,25-(OH)2D on bone are thus
independent of PTH.
I( •
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38
t1,25 (OH)2 D INHIBIT BONE ,
production
\
COLLAGEN
by kidney SYNTHESIS
~
METABOLIC
BONE
t BONE
DISEASE
t GIT calcium RESORPTION >:1
. absorption <f'
/\
Calcium
release
Phosphate
release
/
E~ERCALCAEMIA ]
t
I HYPERCALCIURIA ]
as calcium cannot be used
in bone mineralization
due to phosphate deficiency
t
Normocalcaemla,
Normal PTH
Figure 6: The pathophysiologic effects of h~pophosphatae:-nia
Utilized for
intracellular
metabolism
(' .
39
The demonst.r-a+Lon of the dev -::lopmentof hypophosphat aemi,c
rickets manifesting with the predictable biochemical pattern
(Table 9) in numerous studies on premature infants fed human
milk (54, 57, 58) and standard milk formulas (25), suggests
that in the VLBW infant fed human milk or standard milk
formulas there is insufficient phosporus available for normal
bone mineralization and matrix formation.
The Use of soy-based formulas appears to aggravate this
problem despite their slightly higher calcium and phosphorus
content (Table 6). The probable .ceason for this is the
presence of phytates in these milks which form unabso~bable
complexes with phosphorus, decreasing its bioavailability and
intestinal Jbsorptinn (66).
In view of the fact that hypophsphataemia seems to be the
most prominent feature of MBD, supplementation with
phosphoJ;uS alone has been attempted (57). Howeve' ,
hypocalcaemia was observed (57) despite adequate vitamin D
intake. Greer et al (59) have recommmended calcium and
phosphorus supplementation as the VLBW infant: is calcium as
well as phosphorus deficient.
Factors that may compound the risk of m leral deficiency in
preterm infants must also be considered:
!.
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a. systemio disease and acidosis. callenbach et al (4) and
Bosley at al (45) found a gre.ater prevalence of MBD in the
sicker p:r.-eterminfant. Acidosis secondary to sepsis, poor
perfusion and systemic disease may further contribute to
MBD by increasing bone resorption.
\
b. 'rotal parenteral nutrition has been well documented as a
cause of rickets in VLBW infants reauiring parenteral
alimentation for prolonged Deriods (67). Inadequate supply
of calcium and phosphorus in the solutions administered
and difficulty in inoreasing the concentrations of these
ions plays a primary aetiological role (68).
c. VLBW infant$ requiring ventilatory support for hyaline
membrane disease have a higher prevalence of rickets,
often presenting with incidental rib fractUres on chest
radiographs. Decreas~d miner? 1.. intake as ~.,ellas relative.
fluid restriction, probably playa major role.
d. MBD has been dccumerrced in premature infar.ts receiving
prolonged fUrolsemide ther:ipy (69). FUrosemide I a potent
loop diuretic wh Lch increases urinary catcd.um e~cretion,
is an aggravating factOr compounding the effects of poor
nutritional 'ntake, acidosis and hyperaHmentation.
1.5.5. Calcium pnd....till9sphortW_sp1?12lement~tion
Jt is thus evident from the above discussion that external
sources of mineral supply in either human milk, st:mdard
fo-mulae or soy formulae are inadequate in the fast gr~wing
VLBW infant whose needs approximate thos'a of the foetus.
I
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Provision of additional calcium and phosphorus, i.e 210mg/kg
and 90mg/kg daily intake of calcium and phosphorus
respectively to the VLBW infant to meet the in utero
accretion rates, is s challenge.
Numerous studies have been performed on the supplementation
Of calcium and phosphorus in premature infant feeding.
Hypocalcaemia has been observed following phosphorus
supplementation (57, 58) and Greer et al (70) have suggested
that both phosphorus and calcium supplements are necessary.
Lind:r:othet al (71) showed a decrease in radiological rickets
in breast-fed i~fants below 1000g if calcium and phosphorus
were supplementod.
practical problems occur when calcium and phosphorus are
supplemented and care must be taken in choosing the mineral
preparation. ca Lc i.um gluconat:e or gluceptate in liquid form
and a mixture of mono and dibasic phosphate sa' '-:.sseem to be
the most appropriate (72). simUltaneous supplementation of
both minerals may result in the formation of insolUble salts,
while alternate adm.lnistration of the minerals is likely to
be complicated by high urinary loss of the supplemented
mineral. These Y"roblt'msmay be avoided by adding phosphate to
the milk first and mixing tl,oroughly prior to the add! tion of
calcium (72).
These problems have been addressed in the development of
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specialized premature formulas and br-eaat.-mi.Lk fortifiers.
Different authorities have recommended that phosphorus
content should not be less than 20, 25 or 30mg/100koal in
formulae adapted for premature neonates. Two or three times
these ooncentrations may be given provided the
calcium:phosphorus ratio remains between the limits of 1.1:
and 2.2: 1.
It may also be argued, however, that most premature infants
do not require special supplementation for the following
reasons (41) :
1. Although biochemical evidence of impaired mineralization
is a common finding in l:>reast-fedprematttre infants, most
do not develop any clinical oomplications related to these
changes.
2. FUrthermore, l:>lochemical abnormalities return to normal by
3~4 months of age.
3. Follow-up of these infants does not demonstra'ce any long
term sequelae.
These findings are probal:>lytrue, but it is the sick VLBW
infants weighing less than 1000g at birth who are at greatest
risk of developing MBD and its complications, and attention
should be giVen to preventive therapy in this group.
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1.5.6. Recommendations
1. All VLEW infants should receive 800IO vitamin D daily from
two Weeks post-delivery.
2. Specialized premature. formulas should be used in VLEW
infants on formula feeds.
3. Those infants who are breast-fed should be carefully
monitored for the development of MED and the appropriate
minerals supplemented if MED develops.
4. Soy milk formulas should not be used in VLBW infants
except in exceptional circumstances.
5, VLBW infants receiving prolonged total parenteral
nutrition and with severe postnatal complications should
be monitored for MBD and treated accordingly.
1.5 • 7. SUMMARY
In light of these conflicting views I this study was
undertaken to assess the extent of the problem of metabolic
bone disease in VLEW infants born at Baragwanath Hospital,
and a.lsc to determine the most appropriate feeds for these
infants and the need for active intervention.
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THE BARAGWANATH PERS~f,CTIVE
The maternity section of Ba.ragwanath Hospital .Lb .I.·esponsible
for a total of 36000 deliveries annually - 24000 in-hospital
and 12000 clinic deliveries.
Low-hirth-weight infants «2500g) constitute 14% of all
deliveries and very-low-birth-weight infants «1500g)
approximately 2%. of the VLBW infants 40% are SGA and 60% are
AGA. Thp. Neonatal Intensive Care unit at Baragwanath Hospital
has 12 ventilator beds and the Transitional Care Unit has the
facilities for the management of a further 25 neonates who
are extremely ill, but do not reguire ventilation. !n view of
the large number of deliveries at this hospital and the
relatively few intensive care beds available, it is the
policy of the Neonatal Unit not to ventilate neonates
weighing less than ;~\00g at birth, but to administer all
other therapy as indica.ted. Neonates weighing more than 1000g
are ventilated according to standard indications. Survival of
neonates wei~lhing less than 1000g is approximately 20%. The
high mortality is thought to be multifactorial including the
high incidence of unhooked mothers who at's admitted in
advanced labour. the :ligh incidence of asphyxia and the
policy of not ventilating this group of neonates.
Feeding policies for neonates at Baragwanath Hospital Which
serves the developing community of Soweto are aimed at
promoting breast-feeding. Mothers of VLBW or LBW neonates
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generally stay in hospital with their infants and are
encouraged to express breast milk which is then used to feed
these neonates. Breast feeding is introduced from lBOOg and
bottle feeds gradually weaned until the infants are fully
breast fed prior to discharge from hospital at approximately
1900g.
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CHAPTER 2
METHODS
2.1. Infant selection
All neonates weighing less than 1200g born at Baragwanath
Hospital were entered into the study at birth. The cut-off
weight of 1200g was chosen as this group of neona" .s is at
greatest risk of developing MBD. Exclusion criteria were the
presence of congenital abnormalities (chromosomal and
skeletal), congenital infections or any other diseases which
could themselves cause bone disease. Neonates o..:ing within
the first two weeks post-delivery were subsequently exclUded
as they were unlikely to have developed MBD at this age.
The study was approved by the Committee for Research on Human
Subjects of the UniVersity of the Witwatersrand (protocol no.
8/3/87). Informed consent was obtained from the mothers of
the neonates prior to inclusion in this stUdy. Gestational
age was assessed according to maternal dates and the Ballard
score within 48 hours of delivery (73).
2.2. Anfant feeding
The infants wel'e fed accurdd.nq to the routine feeding
practices of the Baragwanath Hospital Neonatal Unit.
Parenteral fluids administered initially consisted of a 10%
dextrose water solution without additional potassium, but
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containing O.23mg/ml calcium. Potassium containing
electrolyte solutions which ~lso contained O.lmg/ml calcium
and 0.12mg/ml phosphorus were introduced after 48 hours
unless contra-indicated. Parenteral feeds in the form of
amino acid and dextrose mixtures were introduced from the
fourth day of life if indicated by clinical condition. These
feeds contained 0.43 kcal/l, 0.07 mg/ml calcium and 0.08
mg/ml phosphorus,
Enteral feeds consisted of own mother's milk until two weeks
post-delivery when the surviving neonates were entered into
the active phase of the study. At this time, the neonates
were randomised into two groups according to hospital number.
Those with even numbers received own mother's milk only (OMM
or control group) and those 'With odq,numbers received own
mother's milk mixed in equal proportions with a premature
formula of Alprem (mixed feed or MF group) making up the
study group. Alprem contains 0.7 kcal/ml, 0.55 mg/ml calcium
and 0.3 mg/ml phosphorus. The relevant constituents of the
milk feeds are summarised in Table 10. Feeds were
administered three hourly and increased gradually to a
maximum of 180-200 ml/kg/day. Once the neonates reached
1800q, the mothers were encouraged to breast feed, and the
provision of Alprem was stopped, thus a weight. of J.800g, was
used as the end point of the randomized study, although the
infants were followed up for 3 months after discharge.
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TABLE 10. calcium, phosphorus and energy content of own
mother's milk (OMM), Alprem and mixed feeds (MF).
CONSTITUENTS 011-lM Alprem MF
Calcium (mg/l) 255 550 400
Phosphorus (mg/l) 170 300 240
Protein (g/l) 12 24 18
Energy (kcal/l) 650 700 680
Fat (g/l) 33 33 33
vitamin D supplementation of 800 IU/day from Day 14 was
administered, as ,\Tellas oral iron suppLement.at.Lon from one
month post-delivery.
2.3. Monitoring and management
Management of the neonates was determined by the clinician in
charge of each patient. Postnatal complications (prolonged
jaundice, necrotizing e.nterocolitis and duration of
ventilation) were recorded. Volumes and types of parenteral
and enteral fluids were recorded daily and from this daily
calcium, phosphorus and energy intakes were calculated.
Biochemical assessment of bone status which included serum
total and ionized calcium, phosphorus, magnesium, alkaline
phosphatase and albumin wer~ performed at two weekly
intervals until t.ELeinfants weighed 1800 g. Thereafter I the
above paz-amabez s 'Vlereperformed at six weekly intervals for
three visits following discharge. Gruwth parameters of
weight, height and skull circumference were also determined
at the time of those biochemical investiagtions. Serum 25-0HD
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and 1,25- (OH)2D estimations "/eredone at two weeks post-
delivery, on discharge from hospital (1800 - 1900g; and at
the third (final) follow-up visit. Measurement of total serum
calcium and magnesium concentrations were performed by atomic
absorption spectroscony using the Varion Techtron Atomic
Absorption spectrometer and ionized calcium by specific
calcium electrode using the Orion ionized calcium analyser
8S-20. Serum inorganic phosphate, alkaline phosphatase and
creatinine levels were assayed utilizing a Technicon
Autoanalyser II according to methods described b~'H~''st et al
(74), Morgenstern et al (75) and Chasson et al (76)
respectively. Serum albumin levels were assayed by the
B:t'omocresolgreen method of Doumas et al (77), 25-0I1D
according to methods describel by Haddad and Ckyu (78) and
1,25(OH)2D by microassay desc:~ibed by J..'inhardtet al (79).
Radiogr~phs of wrists and distal femur were obtained on
discharge from hospital and at the final follow-up visit or
if the alkaline phosphatase level was greater than 750 lUll
at any stage. Radiographs were reviewed blindly -,d the
presence of periosteal reactions, osteopenia and/or rickets
recorded.
Data was analysed using analysis of variants and Chi-square
procedures.
V .;,."'
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CHAPTER 3
RESULTS
3.1. clinical characteristics of control and study groups
A tot",l of 121 neonates weighing less than 1200g at birth and
born at Baragwanath Hospital between February and October
1987 were assessed as possible candidates for inclusion in
the study. There were 56 survivors at two weeks
postgestational age and these were then entered into the
randomized trial. Those neonates who died before two weeks of
age were not included in the study. Of the 65 ~eonates who
died prior to two weeks, only 32 were assessed for
gestational age prior \..0 their deaths. The major '.!!Ie.son for
the lack of gestational age assessment of this grOl!p';Tasthe
severity of illness and the short duration of survival.
Fifteen Qf the 32 (47%) were appropriate for gestational age
compared \dth 8/56 (14%) surviving neonates (p=o.002). The
majority of the deaths were due to extreme prematurity.
Of the survivors, 27 received own mother's milk (OMM) and 29
received mixed feeds (MF). 'l'hreeinfants in the OMM group
Wbre subsequently excluded as they had receiv~~ incorrect
~deds. Table 11 summarizes the characteristics of the
neonates in each group. There were no statistically
significant differerces between the two groups in the
parameters assessed at birth or at two weeks of age when they
entered the r'andonu.sedtrial.
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TABLE 11. Comparison of the clinical characteristics of the
neonates in the control (OMM) group and study (MF) group.
OHM GROUP I MF GROUP..
No. in randomized study 29 27
No. completing in 29 24
hospital study
No. completillg follow-up 16 14
Mean gestational age (wks) 32.8 ± 1.3 32.6 ± 1.3Mean birth weight (gm) I 1095 ± 99 1091 ± 80AGA 4 4SGA I 25 20Multiple pregnancies 4 2
ventilated (n) 3 2
Septicaemia (n) 6 3Exchange transfusion (n) 3 2
Enterocolitis (n) 1 1Hospitfll stay (days) '52± 11 55 ± 14
3.2. Anth:t'opometricresults
Weight gain was similar in control and study groups as shown
in Figure 7. Both groups followed the expect.edpattern of
weight gain when plotted on the Dancis Premature-Birth Weight
Chart (80). Minimal weight loss occurred for the first ten
days. This was then followed by weight S n which appeared to
plateau after week 5 and increase again following discharge
from hospital.
Growth, as assessed by increase in length and skull
circumference was not statistically differ~'l1tin the control
and study groups as shown in Figures 8 and 9. The changes in
both these parameters followed a similar pattern to those
found in weight, although the infants who had rec ived the
mixed feed while in hospital were statistically longer than
the breast-fed group at the second and 'third follow-Up
,.. ; .. .t
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Figure 7. Changes in weight during study period in control and study groups.
(FU1 c 6 weeks post discharge; FU2 '" 12 weeks post discharge;
FU3 = 18 weeks post discharge). (n) ee no. in each group.
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Figure 8. Changes in length during study period in control and study groups.
(FU1 ::: 6 weeks post discharge; FU2 = 12 weeks post discharge;
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Figure 9. Changes in skull circumference during study period in control and study
group!), (FU1 "" 6 weeks post discharge; FU2 == 12 weeks post discharge:
Ftl3 = 18 weeks post discharge).
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3.3. Energy, calcium and phosphorus intakes
These intakes were calculated according to the various milk
constituents as shown in Table 10.
3.3.1. Energy intake (Figure 10).
The energy content of the milk feeds used in the control and
study groups was only s~.ightly different (650 and 680kcal/l
respectively; Table 10), therefore a significant difference
in energy intake between the two groups was not anticipated.
Energy intake was minimal in the first week post-delivery land
then increased progressively over the next two weeks as the
volume of milk intake Lncz'eaaeo , Energy intake had reached a
pl.at.aauby four weeks post-delivery at approximat1aly
130kcal/kg/day once maximum milk intakes of 200ml/kg/day were
administered.
3.3.2. Calcium intake (Figure 11).
Calcium intakes in the control and study groups were minimal
in the first week of life and Lnor-aasd sharply over the next
two weeks as the volume of feeds increased. The g:t'adientof
Lncz'eaae was greater in the study group which reached a
plateau at an intake of approximately 80mg/kg/day from 4
weE'lksof life. The control group reached a pl.atieauat a.
similar time but at a Lowar intake of 50mg/kg/day. The
differences in intakes between the two groups was
statistically significant (p<O.OOOl) from week 3 until
discharge from hoep i.tial..
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3.3.3. Phosphorus intake (Figure 12).
Phosphorus intakes followed a similar pattern to that of
calcium intakes. The phosphorus intake was significantly
greater in the study group reaching a steady state at 45-
50mg/kg/day compared with 35mg/kg/day phosphorus intake in
the control group (p<O.OOOl).
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Figure 12. Phosphorus intake during hospitalization in control and study groups.
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3.4. BiocI'~mical Finding_e
3.4.1. Serum albumin levels (Figure 13).
serum albumin levels were initially similar in both groups.
Values in the study group remained relatively constant
th):"oughoutthe hospital stay, whlie in the control g):"oupmean
levels fell from six weeks of age. The study group had
significantly higher values than +:hecontrol group at weeks
eight and ten. After discharge, values in both groups rose
progressively to reach normal paediatric values.
3.4.2. Serum magnesium levels (Figure 14).
Magnesium levels remained stable and within normal limits
throughout the s+udy period in both groups.
3.4.3. Serum total and ionized calcium concentrations
(Figures 15, 16).
There was no statisticr"l.llysignificant difference in serum
calcium (total and ionized) levels between the control and
study groups, despite different calcium intakes (Table 10).
The graphs of the mean serum concentrations of total and
ionized calcium fo11o",'similar curves indicating that total
serum calcium levels were not affected by changes in serum
albumin. Serum ionized calcium levels in boch OMM and MF
groups Were lowest at 2 weeks of age (approximately
2.05mEgJI) and increased gradually until 8 weeks of age
(about 2.2mEgJI). The levels then remained stable for the
remainder of the in-hospital stay. Following discharge, serum
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ionized calcium levels increased further (2.4 ± O.lmEqJl) to
reach normal paediatric values.
3.4.4. Serum phosphorus levels (Figure 17).
Serum phosphorus levels decreased post-delivery (2.1 ±
0.4mmol/l at 2 weeks) to their lowest level at 10 weeks (1.58
± 0.3mmol/l). Levels rose again following discharge from
hospital, and remained constant during the follow-up period.
There 'vere no statistically significant differences between
the two groups, despite higher phosphorus intakes in the
study group.
3.4.5. Serum alkaline phosphatase levels (Figure 18).
Serum alkaline phosphatase levels increased progressively in
both the own mother's milk and mixed feed groups reaching
peak values at 10 weeks post-gestational age. As the values
at each time point were not normally distributed, the data
were log transformed and these values compar-ed between the
two groups. The own mother's milk (control) group tended to
have higher alkaline phosphatase levels during the in-
hospital study period. This difference was highly significant
at the time of discharge from hospital (t=4.3; p<O.OOOl). No
difference was found at the time of entry or discharge from
the study. Using a cut-off level of 750IU/l AP as highly
suggestive of rickets, the 0I1Mgroup had a greater nn:mber of
infants above this level, but this did not reach statistical
significance (Chi-square 3.01; p=0.08).
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3.:'.6. Serum 25-hydroxyv~t.amin D levels (Figure 19).
Serum 25-0HD values were meas zred at two weeks post-delivery,
on discharge from hospital and again at discharge frOln the
study. Values were within the normal range (lO-50ng/ml) at
all times. In the contrrol group, va Lues zema.i.nedconstant
wh iLe the infants were in hospital, but then rose sharply
(P<0.0004). In the study group, levels rose progressively at
the three time points (p<O.OOOl and 0.007 respectively). At
entry into the study (two weeks of age), the control group
had significantly higher values t.han the study group
(p<0.04), while at hospital dischar.ge, the pattern had
reversed with the study group having higher values than the
control group (p<O.Ol). At follow-up, the levels in the two
group$ were similar.
3.4.7. Serum 1,25-dihydroxyvitamin D levels (Figure 20).
Serum 1,25-(OH)2D, measured at the same times as 25-0HD
followed a similar trend in both groups. There was an overall
two-fold increase in 1,25-(OH)2D levels which occurred from
the time of entry into the study to hospital discharge
(P<O.Ol in both groups). Values then tended to decrease.
. .
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Figure 13. Serum albumin concentrations during study period in control and study groups.
(FU1 = 6 weeks post discharge; FU2 = 12 woeks post discharge;
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Figure H. Serum phosphorus concentrations during the study in control and study
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Combining the data from the three time points (i.e. at two
weeks of age, at hospital discharge and at; final follow-up),
a negative correlation was found between 1,25-(OH)2D and
phosphate in both groups, although it only reached
statistical significance in the study group (r=0.25, p=O.026)
(Figures 21 and 22). A similar significant negative
correlation was found bs,tween alkaline phosphatase and serum
phosphate in both the study and control groups (r=0.43,
p<0.01 and r=-0.51, p<0.01 respectively) (Figures 23 and 24).
There was no correlation between serum alkaline phosphatase
levels and serum ionized calcium in either group (OMM group
r=~0.05, p=O.68; MF group r=0.004, p=0.97). There was a
positive correlation between 1,25-(OH)2D and serum ionized
calcium (OMM group r=0.28, p=O.03; MF group r=0.37, p<O.Ol).
A positive correlation was found between serum alkaline
phosphatase levels and 1,25(OH)2D, the cor.relation reaching
significance in the study group (r=0.25, p=O.026) (Figures 25
and 26). Ther.e was no correlation between serum 1,25-(OH)2D
and 25-0HD levels in the own mother's milk group (Figure 27),
however, in the mixed feed group a significant positive
correlation was found 1,25-(OH)2D and 25~OHD when assessed
over the entire duration of the study period (Figure 31).
When the data was divided into the specific time intervals, a
sianificant correlation was only obtained at the time of
discharge from hospital (r=O.4, p=0.03) (Figures 32-34).
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3.5. Radiological findings
Radiological findings in both groups on discharge from
hospital and at the final follow-up visit are summarized in
Table 12.
TABLE 12. !.::evalenceof radiological findings in control and
study groutJs on discharge from hospital and at final follow-
up visit. (OMM = own mother's milk; MF = mixed feed).
I OMM MF
Discharge Follow-up Discharge Follow-up
Periosteal 9/23 I 2/15 11/26 0/18
reaction 39% 13% 42% 0%
osteopenia 6/23 4/15 8/26 5/18
2690 27% ~l% 28%
Rickets 3/23 1/15 0/26 1/18
13% 7% 0% 6%
There were no statistically significant differences in
radiological findings in the control and study groups.
Periosteal reactions were noted in just over one third of
patients ~t the tim~ of discharge from hospital. ThE!
prevalence had dropped markedly by the time radiogralphs were
repeated at the last follow-up visit. Those infants with
periosteal reactions tended to have higher alkaline
phosphatase levels (822 ± 432IU/l) than those without
periosteal reactions (677 ± 242IU/li t=1.31, p=0.098). The
prevalence of osteopenia did not change significantly betWE~en
the time of discharge from hospital to the final follow-up
visit. The":e was no difference in alkaline phosphatase values
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in infants with or without evidence of osteopenia (734 ±
386IU/l and 781 ± 256IU/I respectively; t=O.41, p=O.34).
Radiological rickets was an infrequent finding, despite the
elevation of alka' . "hosphatase values in the majority of
infants at hospital discharge. In all cases, the severity of
rLcket.ewas mild with only minimal loss of the metaphyseal
plate and slight splaying and irregularity of the metaphysis.
Although only five infants had radiological rickets, alkaline
phosphatase levels Were significantly higher in this group
than in those infants without rickets (1153 ± 668IU/l and 709
± 286IU/l respectively; t=2.73, p=O.005).
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CHAPTER 4
DISCUSSION
Metabolic bone disease is a well recognised problem in
premature infants and in particular in VLBW infants fed
,
breast-milk (42, 61). Radiologic rickets is, however, an
uncommon finding, although osteopenia and biochemical
evidence of MBD (hypophosphataemia and elevated alkaline
phosphatase levels) are frequently noted in the first three
months of life (1). The premature infant, especially the
VLBW has increased mineral requirements (8). It is generally
accepted in first world countries that VLBW infants should be
fed premature milk formula whLch has been specifically
modified to cater for these needs (42). However, at
Baragwanath Hospita.l, which Serves mainly the disadvantaged
community of Soweto, the Neonatal urtithas a policy of
encouraging breast-feeding where possible. The use of a
premature milk formula as the sole feed for VLBW infants
would reduce the prevalence of breast-feeding in this group
of infants, which might adversely affect the long-i:erm
survival of these infants once they are discharged from
hospital. ThE!prevalence of MBD and altered mineral
homeostasis is unknown in the VLEW population at Baragwanath
Hospital. This study was, therefore, designed to assess the
prevalence and to determine the effect of supplementing
breast-milk with a premature infant formula. In this study,
tv.ogroups of VLBW infants (one fed own mother Is milk and the
other fed a combination of premature formula and breast-milk)
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born at Baragwanath Hospital were monitored for differences
in growth, and biochemical and radiological development of
metabolic bone disease. By combining the premature formula
with breast-milk, the increased mineral and energy content of
the prrematiur-eformula is effect.ively diluted. This could
explain many of the sLmd.LazLt.i.esin results between the two
groups, which migrht otherwise have been more evident.
The high neonatal mortality rate in the immediate postnatal
period occurred in mainly AGA neonates weighing less than
1000g at birth with severe hyaline membrane disease. The
survivors that were subsequently enrolled in the study were
mainly small-for-gestational age infants who did not have the
problems of extreme prematurity.
Anthropometric growth parameters of weight, height and skull
oLz-cumfez-enoa followed similar patterns in the control and
study groups. The energy content of the two feeds was similar
(650kcal/l in o~m compared with 680kcal/l in the MF group) ,
therefore this finding was not unexpected. The growth
patterns also matched acceptable standards of gro'Vlthfor
premature infants (80). Although the infants fed breast-milk
had significantly lower serum albumin levels in hospital,
reflecting the lower protein content of breast-milk, this did
not affect growth. With regard to growth in this group of
infants, it is therefore, acceptable to continue with current
feeding practices at Baragwanath Hospital Which aims at
82
encouraging and establishing breast-feeding in all newborns
at the hospital.
Hillman et al (25) have defined four factors which appear to
be important in mineral homeostasis in the VLBW infant. These
are birth weight, mineral availability, serum 25-0HD
concentrations (reflecting vitamin D status) and post-
conceptional age.
calcium and phosphorus intakes in both the control and study
groups were suboptimal (29). The highest calcium and
phosphorus intakes were attained in the study group
(95mg/kg/day calcium and 56mg/kg/day phosphorus) compared
with recommended intakes of 200mg/kg/day calcium and
loomg/kg/day phosphorus (72). Although the control group had
significantly lower intakes of both minerals, this was not
reflected in the serum calcium or phosphorus concentrations
which were similar in both groups. Ionized serum calcium
values were also similar in both groups. Normal values for
serum cal~ium and phosphate in the VLBW infant have not been
defini,tively determined. concentrations of these minerals
increased in all infants in this stUdy following discharge
suggesting that the in hospital levels were below normal.
This fact in conjunction with the documented suboptimal
mineral intake would suggest that the infants in both control
and study groups were deficient in calcium and phosphorus.
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In this study, as in studies by Hillman et al (25) and Brooke
et al (1), radiologic rickets was an infrequent finding, but
periosteal reactions and osteopenia as well as raised
alkaline phosphatase levels occurred frequently suggestive of
the presence of metabolic bone disease. Alkaline phosphatase
is an indicator of osteoblastic activity and also bone
turnover and levels five to six fold above normal reflect
impaired bone mineralization and MBD (44, 49). In this study,
alkaline phosphatase levels were significantly higher in
those infants with radiological rickets and wer.e also higher,
although not significantly so, in those infants with
periosteal reactions. These findings are suggestive of
biochemical and radiological evidence of MBD, although they
must be interpreted with reservation in view of the small
.".1mberof infants affected and the wide st.andard deviation.
The diagnosis of osteopenia is a subjective assessment and
observer dependent and is, therefore, not as reliable a sign
of MBD as are periosteal reactions and frank riCkets. The
failUre to demorJ~trate a rise in alkaline phosphatase in
association with osteopenia is thus not unexpected. Alkaline
phosphatase levels rosa simultaneously with a drop in serum
phosphate suggestirq the presence of MBD and possible
phosphate deficiency. The increase in alkaline phosphatase
levels and the negative correlation of alkaline phosphatase
with serum phosphate that were found in the both groups are
also suggestive of mineral deficiency.
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It is suggested that these biochemical abnormalities are
secondary to phosphate insufficiency (63). The typjcal
biochemical abnormalities that occur in phosphorus deficiency
are hypophosphataemia, hypophosphaturia and hypercalcaemia
(63). The low phosphorus content leads to a decrease in
serum phosphorus whLch has a direct impairment on bone
mineralization. The decrease in aeruni phosphate concentration
also has an indirect effect on bone mineralization by its
stimulation of l,25-dihydroxyvitamin D production by the
k.idney,which in turn leads it.O increased bone resorption and
bone turnover resulting in increased alkaline phosphatase
values. The significant increase in l,25-dlhydroxyvitamin D
levels in both groups prior to discharge from hospital is
suggestive evidence of stimulation vf l,25(OH)2D production
by mineral (calcium and/or phosphorus) insufficiency. Several
correlations found in the present study in both groups of
infants support the hypothesis of primary phosphate
deficiency. The negative correlation between serum 1,25-
(OH)2D and serum phosphate which was significant in the mixed
feed group and approached significance in th.ebreast-fed
group is indicative of stimulation of 1,25-(OH)2D production
by low serum phosphate. This also confirms previous work
demonstrating that renal hydroxylation of 25-0HD to 1,25-
(OH)2D is adequate (3~, 33). The positive correlation found
between alkaline phosphatasl? and l,25(OH)2D in both groups is
suggestive of increased bone turn-over stimulated by
l,25(OH)2D in an attempt tc maintain serum phosphate
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concentrations within normal, thereby completing the cycle.
The lack of correlation between serum calcium and alkaline
phosphatase suggests that calcium deficiency did not play a
r'ole " the development of metabolic bone disease in the
control or study groups in this study. The finding of a
significant positive correlation between serum calciunland
1,25(OH)2D suggests a relative calcium excess in the face of
phosphate deficiency adding further support to the hypothesis
that primary phosphate deficiency is the major aetiological
factor in altered mineral homeostasis.
Parathyroid hormone concentrations were not measured in this
study and, therefore, could not be correlated with changes in
vitamin D metabolism.
Numerous studies have confirmed that the supplementat~on of
calcium and phosphorus to the feeds of VLBW infants may
prevent the development of MBD. It waG not possible to fully
assess this aspect in this study as neither feed supp2ied the
required amount of calcium or phosphorus in order to achieve
in ut.cro accretion rates. The concentration of l ~rals
supplied in the modified premature formula was negated in
tpis study by its dilution with own mother's milk. However,
the study group did have lower alkaline phosphatase values
than the control group, suggesting that the additional
calcium and phosphorus did reduce the severity of the
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pertubations in mineral homeostasis.
As reported by Hillman et al (25), serum concentrations of
25-hydroxyvitamin D are also a determining factor in the
development of metabolic bone disease. 25-0HD is the major
circulating form of vitamin D and is thus a reflection of
vitamin D status (5, 6). The premature infant has increased
vitamin D requirements (800rU/day), although no definitive
evidence of immaturity in the metabolic pathway of vitamin D
has been docunented (30-33). rnmaturity of the hepatic
hydroxylation system has been documented, but is ~f doubtful
significance. Abnormalities of vitamin D metabolism p~obably
do not playa major role in the pathogenesis of MBD provided
that an adequate vitamin D intake is supplied. All infants in
this study received 800ru vitamin D from two weeks of age.
The mixed feed group in this study had a significant
increase in serum 25-0HD levels prior to discharge from
hospital, while in the breast-milk fed group in whom the
increase only occurred following hospital discharge. This
might be accounted for by the slightly higher vitamin D
intake in the mixed feed group (approximately 100rU/day) due
to that contained in the premature formula. rt is possible
that this vitamin D is also available in a more readily
absorbable form. rt is unlikely that inadequate hepatic
hydroxylation played a role as this would have been evident
in both groups. The lack of correlation between l,25(OH)2D
and 25-0HD levels in both groups at birth and on discharge
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from the study is in keeping with vitamin D repletion. The
tendency towards a positive correlation between these two
parameters prior to hospital discharqe may suggest a relative
vitamin D deficiency despite adequate intake, although the
nUl\ber of cases in ~ach group at this time is too small for
definitive comment.
Decreasing gestational age and birth-weight (25, 37), and
systemic disease and acidosis have also been shown to be
predisposing factors in the development of MBD. The majority
of infants finally enrolled and completing this study were
small-for-gestational age who had minimal number of post-
natal complications considering their birth-weight. The AGA
infants weighing under 1000g at birth and in whom a higher
prevalence of MBD would have been expected, were self
exclv0ing by virtue of Baragwanath Hospital policy of not
ventilating neonates born less than 1000g. Theso factors
might explain the relatively low prevalence of radiological
rickets in the population studied.
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CQNCLUSION$.
1. Overt r Lcket.s is not a maj or problem in very low-birth-
weight infants; born at Baragwanath Hospital, although
biochemical evidence as assessed by raised serum alkaline
phosphatase LeveLs I and radiological evidence as assessed
by periosteal reactions and osteopenia occurs frequently.
2. Hypophosphatamnia, normocalcaemia and raised 1,25-
dihydroxyvitarlin D levels support the hypothesis of
phosphate deficiency as a primary cause of metabolic bone
disease.
3. The mixing of breast-milk with a specialized premature
milk formuliJl{Alprem) has no maj ot'advantage on weight
gain and growth, or on the development of metabolic bone
d Ls aaae in vezy low-birth-weight infants.
4. It is recommended that the use of CMn mother's milk be
encouraged in the light of these results and that current
feeding practices of very low-birth-weight infants at
Baragwanath H()spital be continued with the aim of
establishing breast-feeding.
s. Biochemical mc::mitoring,especially that of alkaline
phosphatase, ehcu.Ld be performed in very low-hirth-weight
infants. ThoSl:lwith elevated levels greater than 7501U/l
should be fUrt:her investigated and supplemented with
calcium and phosphate if necessary.
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